Corporate Board Profile
Tech Score: 50/100
1 mention(s) identify YOUNG T. KWON as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ADMA BIOLOGICS, INC. | 2022-04-28 | Dr. Kwon received a B.S. in Biology from the Massachusetts Institute of Technology and a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University. Dr. Kwon was chosen to serve of the Board as a recognized leader in the healthcare sector and because of his deep strategic and financial experience. | Dr. Kwon has a B.S. in Biology from MIT and a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University, with experience in biotech and venture capital, indicating strong technical and scientific background potentially including programming skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-28 | Dr. Kwon received a B.S. in Biology from the Massachusetts Institute of Technology and a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University. Dr. Kwon was chosen to serve of the Board as a recognized leader in the healthcare sector and because of his deep strategic and financial experience. |
| 2023-04-13 | Dr. Kwon received a B.S. in Biology from the Massachusetts Institute of Technology and a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University. Dr. Kwon was chosen to serve of the Board as a recognized leader in the healthcare sector and because of his deep strategic and financial experience. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-19